Nurse Practitioner, Family · Temecula, CA
NPI
1811384365
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
31625 de Portola Rd Ste 101
Temecula, CA, 92592
Phone (951) 501-4200
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$684K
1,712 prescriptions
Company payments, 2025
$1,302
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Teresa Geisinger prescribed most often to Medicare patients was Rabeprazole Sodium, with 287 prescriptions and refills. In total Teresa Geisinger wrote 1,712 Medicare prescriptions that cost $684K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rabeprazole Sodium Generic | 287 | 498 | 91 | $10K |
| Famotidine Generic | 250 | 408 | 76 | $2,859 |
| Pantoprazole Sodium Generic | 203 | 369 | 78 | $1,937 |
| Dicyclomine Hcl Generic | 80 | 108 | 27 | $1,377 |
| Dexlansoprazole Dr Dexlansoprazole | 80 | 148 | 24 | $24K |
| Nortriptyline Hcl Generic | 75 | 77 | 17 | $374 |
| Linzess Linaclotide | 66 | 85 | 25 | $44K |
| Colestipol Hcl Generic | 61 | 88 | 13 | $6,059 |
| Omeprazole Generic | 57 | 96 | 25 | $649 |
| Ondansetron Odt Ondansetron | 55 | 56 | 20 | $1,555 |
| Creon Lipase/Protease/Amylase | 47 | 59 | 14 | $268K |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 46 | 46 | 43 | $8,042 |
| Lubiprostone Generic | 33 | 35 | Under 11 | $2,944 |
| Xifaxan Rifaximin | 22 | 22 | Under 11 | $63K |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 21 | 21 | 21 | $3,014 |
Brand drugs: 336 claims; generic drugs: 1,376 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Teresa Geisinger $1,302 ($1,302 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $341.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 22 | $341 |
| Madrigal Pharmaceuticals MDGL | 7 | $292 |
| Inspire Medical Systems, Inc. INSP | 1 | $119 |
| Vivus LLC | 4 | $85.58 |
| Genzyme Corporation SNY | 3 | $83.74 |
| Ardelyx, Inc. ARDX | 4 | $73.22 |
| Pfizer Inc. PFE | 3 | $65.69 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $61.64 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $45.8 |
| Janssen Biotech, Inc. JNJ | 2 | $42.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.